All filters
Slidesets
Georgia - Tengiz Tsertsvadze MD, PhD
Presented at:
European Roundtable on Hepatitis Cure & Eradication 2015
Slidesets
Germany - Heiner Wedemeyer, MD
Presented at:
European Roundtable on Hepatitis Cure & Eradication 2015
Slidesets
Progression of the Disease - Heiner Wedemeyer, MD
Presented at:
European Roundtable on Hepatitis Cure & Eradication 2015
Slidesets
Mortality Projection in the Coming Years - Maria Buti, MD, PhD
Presented at:
European Roundtable on Hepatitis Cure & Eradication 2015
Slidesets
New Screening Testing Technologies - Stéphane Chevaliez, PharmD, PhD
Presented at:
European Roundtable on Hepatitis Cure & Eradication 2015
Slidesets
Poland - Robert Flisiak, MD, PhD
Presented at:
European Roundtable on Hepatitis Cure & Eradication 2015
Slidesets
Global Plans - The Toronto Declaration - Charles Boucher, MD, PhD
Presented at:
European Roundtable on Hepatitis Cure & Eradication 2015
Slidesets
Unmet needs and challenges of the current antiretroviral treatment in South Africa - Michelle Moorhouse
Presented at:
Optimal HIV Management Course, Africa 2015
Slidesets
Optimization of HIV Management - Saye Khoo, MD, PhD
Presented at:
Optimal HIV Management Course, Africa 2015
Slidesets
Management of Drug Interaction in practice - Saye Khoo, MD, PhD
Presented at:
Optimal HIV Management Course, Africa 2015
Slidesets
Management of Co-Morbitidies - Mark Nelson, MA, MBBS, FRCP
Presented at:
Optimal HIV Management Course, Africa 2015
Slidesets
Management of HIV Co-Infection - Mark Nelson, MA, MBBS, FRCP
Presented at:
Optimal HIV Management Course, Africa 2015
Slidesets
Tyrosine Kinase Inhibitor (TKI) - B. Lum
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
A pre-clinical PKPD framework for biomarker led - R. Jones
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
A survey of new oncology drug approvals in the [...] - B. Lum
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Dose escalation of tamoxifen in patients with low ... -C. Lee
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Toxicity-adjusted dose (TAD) of sunitinib - H. Gurney
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Dried blood spot sampling for therapeutic drug - D. De Wit
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Drug-drug interactions in patients ... - R. van Leeuwen
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Dose Individualization in H[...] - Courtney Fletches, PharmD
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Everolimus exposure strongly related to dose [...]-D. De Wit
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Marker of bevacizumab efficacy - C. Serdjebi
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015
Slidesets
Microdosing as a pharmacokinetic assessment tool - W. Vaes
Presented at:
International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015